76 – Introduction to Drug Manufacturing & Scale-Up (S6E1)

Have you ever thought about the journey of a
drug? From a tiny little bit of powder in the
lab to a pill that you might take. It's kind
of amazing when you think about it. Oh yeah,
for sure. People get really excited about those
big breakthrough moments when a new drug is discovered.
And that's totally understandable. But there's
this whole other phase that's, well. It's not
as glamorous, but it's just as important. It's
taking that tiny little molecule and figuring
out how to make enough of it to actually help
people. Right, so it's not just about the science.
It's also like a massive engineering challenge,
right? Absolutely. You're basically going from
like a small kitchen experiment to something
like a giant food factory, you know? It's a huge
jump in scale. And for this deep dive, you've
gathered a bunch of material from all these different
angles. We've got stuff on the initial hurdles
in developing the drug and then all the crazy
details of how they actually manufacture it and
even the whole regulatory side of things. It's
pretty comprehensive. Yeah, I tried to cover
all the bases. What we're really trying to do
here is break down the key concepts and show
you what are the big challenges that come up
when you try to scale up production of a new
drug. It's going from making like milligrams
in a lab to kilograms or even tons in a factory.
OK, so let's start at the beginning. We've got
this like magical image of a scientist in a lab
creating a brand new molecule. Yeah, kind of
like that drug discovery. almost always starts
with making a new chemical entity. We call it
an NCE, for short. And we actually get to see
a little bit of that in the sources. Like, one
of the articles describes the synthesis of this
pretty complex molecule. It's called, get this,
5 -chloro -2 -methoxaphenyl -3 -fluoro -5 -trifluoromethyl
-phenymethanone -7. Wow, that's a mouthful. Right.
And then there's another one that mentions Bacca
-malflufin. These are like the first real versions
of a potential drug. And they're made using these
really careful carefully planned out chemical
reactions. So they have these like small scale
methods that work in the lab. Can't they just
make the experiments bigger, just multiply everything?
You'd think so, right? It sounds like it should
be that easy. But things get tricky when you
try to scale things up. Those initial ways of
making the drug, they're fine for making small
amounts for research. But when you try to do
it on a factory scale, you run into problems.
Think about it like this. You have a recipe for,
say, a really delicate cake. It might turn out
perfect in your kitchen. But if you try to make
1 ,000 of them in a giant bakery oven without
changing anything, it's probably going to be
a disaster. I see what you mean. So it's not
just about making more of the stuff. It's about
changing the recipe itself to work on a larger
scale. Exactly. And that's where a whole bunch
of factors come in, like how much of the drug
you actually get from the starting materials.
That's called the yield and the cost of all the
ingredients. And you have to think about safety,
too, because handling large amounts of chemicals
can be risky. Right, that makes sense. So it's
not just about creating the molecule. It's about
figuring out the most efficient and safe way
to manufacture it in huge amounts. Yeah, it's
like turning a cool science experiment into a
reliable and efficient factory process. And that
brings us to some key concepts in manufacturing.
Have you ever heard of process chemistry? I can't
say I have, but it sounds intriguing. So it's
like the art of taking something that works in
a lab and making it work in a factory. It's not
just finding any way to make the molecule, it's
finding the best way. The safest, the cheapest,
the one that gives you the most drug with the
least waste. You know, one of our sources talked
about how they optimized the synthesis of this
thing called R3 -amino -6 -caro -D -fluorochroman
-2, and they had to make kilograms of it. That's
process chemistry in action. Optimization. So
it's like fine -tuning every step, but with a
focus on industrial production. What exactly
are they tweaking? Lots of things. First off,
they need to think about where they're going
to get all the starting materials and how much
they're going to cost. If the ingredients are
rare or super expensive, it's going to make the
final drug really expensive, and that's a big
problem. Then there's the issue of waste. A lab
experiment might produce a tiny amount of byproduct,
but a factory could make tons of it, and some
of that stuff can be pretty nasty. So they're
always looking for ways to minimize waste and
make the whole process more environmentally friendly.
Okay, so we've got this shift from the lab to
the factory. What are some of the big challenges
that pop up during the scale -up? Oh, there are
a bunch. Yield and purity are big ones. You know,
in the lab it's easier to control things, so
you get more of the drug and it's purer. But
when you scale up, things change, like how well
things mix together or how the heat is distributed.
That can really mess with your yield and make
the drug less purer. There's this example in
one of the articles about Melflufin HCl, and
the initial yield was only 32%. That's not enough
to make a commercially viable drug, so they had
to like get in there and figure out what was
going wrong and optimize each step. 32%. Wow,
that's a huge difference. What are the challenges
do they face? Well, safety is a big one. You
know, when you're dealing with large amounts
of chemicals, things can get dangerous. Some
of these chemicals are flammable, corrosive,
or even toxic. So they have to build special
facilities with all these safety features like
negative pressure systems and HEPA filters to
protect the workers and prevent anything from
like leaking out into the environment. So it's
a big step up in terms of infrastructure. Oh
yeah, for sure. And then you've got process optimization
itself. You know, what works perfectly in a small
flask in the lab might not work at all in a giant
reactor. It's like trying to bake that cake in
a totally different oven. One example is where
they had to switch the solvent they were using,
like going from dichloromethane, that's CH2Cl2
for short, to tetrahydrofuran or THF. And then
there's another example where they had to be
super careful about which base they used in a
Suzuki coupling reaction. These little changes
can make a big difference. Wow. I wouldn't have
thought that changing a solvent could have such
a huge impact. It can be surprising, right? Yeah.
And then there's the whole issue of isolating
and purifying the drug after the reaction is
done. They use techniques like crystallization,
filtration, and distillation, but scaling those
up can cause problems. One article talked about
how they were using a continuous flow reactor,
and the product kept precipitating out and clogging
the equipment. So even separating the good stuff
from the bad stuff becomes a whole engineering
change. Yeah, so many things to consider. What
about making sure that every batch of the drug
is the same? and meets the quality standards.
Yeah, that's super important. They call it reproducibility
and quality control. You can't have one batch
that's like super potent and another that's weak.
So there are all these strict rules and regulations
that they have to follow. And they have entire
teams of people whose job is just to make sure
that everything is done perfectly. So it's not
just about the science, it's also about all these
regulations. Absolutely. The pharmaceutical industry
is one of the most heavily regulated industries
out there. They have to make sure everything
is documented, they have to follow specific procedures,
and every batch of the drug has to be tested
to make sure it meets the standards. You mentioned
some real -world examples from this journal called
OPRND. I think it stands for Organic Process
Research and Development, right? Yeah, that's
the one. It's full of these case studies that
show how researchers solve these scale up problems.
For example, there's one article where they talk
about making R3 -amino -6 -furo -8 -difluorochroman,
which is like a building block for a drug. They
managed to do something called telescoping, where
they combine multiple steps into one. It's kind
of like doing a bunch of cooking steps in the
same pot to save time. They did this to improve
the efficiency and reduce waste, but it required
a ton of optimization, especially for this one
step. called ketone reduction. Telescoping, that's
a neat trick. Yeah, it is. But you have to be
really careful because the conditions for each
step have to work with the next one. There's
another cool example where they had to scale
up these reactions called acetylation and nitration.
They were making an intermediate for osmirtinib,
which is a lung cancer drug. Nitration reactions
can be really dangerous because they can like
explode if you're not careful. So they use this
technology called continuous flow where the reaction
happens in a tiny stream which makes it much
safer and more efficient. So it's like a controlled
stream instead of a big batch which makes sense
for safety. Yeah. Exactly. And they also talk
a lot about optimizing Suzuki coupling, you know,
that reaction I mentioned before for connecting
carbon atoms. They experiment with different
solvents like THF and dioxane and different bases
like potassium acetate and sodium carbonate to
get the best results. It's like a puzzle, figuring
out the perfect combination of ingredients and
conditions. Right. It's all about finding the
perfect balance. Absolutely. And then after all
the reactions are done, they have to purify the
drug. They often use crystallization for that
where they basically grow crystals of the drug
and they have to be super precise with the conditions
like the solvent the temperature and even adding
tiny seed crystals to start the process. So they're
not just chemists they're like crystal growers
too. You could say that they're controlling matter
at a molecular level to get the pure drug and
all of this like we talked about before has to
be done under strict regulations to ensure the
safety and quality of the final product. Wow.
This deep dive has been a real eye -opener. I
had no idea how much went into making a drug.
It's pretty mind -blowing when you think about
it. Taking a drug from a tiny speck in a lab
to a pill that millions of people can take is
a huge accomplishment. It involves so much science,
engineering, and meticulous planning. Yeah. And
it makes you appreciate that little pill a lot
more, knowing all the work that went into it.
For sure. And it also brings up another interesting
point. Since they're making so much of these
drugs, we have to think about the environmental
impact. There's a whole field of research dedicated
to making these processes greener and more sustainable.
They even mentioned greener fluorination in one
of the articles, which is pretty cool. Right.
Sustainability is such an important issue these
days. Absolutely. It's all connected. So that's
the journey of a drug in a nutshell. From a tiny
molecule in a lab to a life -saving medicine,
it's a long and complex process, but it's one
that's absolutely crucial for human health. This
deep dive has been truly fascinating. Thanks
for taking us on this journey. My pleasure. There's
so much more we could talk about. But I hope
this has given you a good overview of the challenges
and triumphs of drug manufacturing. It certainly
has. And for our listeners, if you're interested
in learning more, I encourage you to dive into
some of the resources we mentioned. It's a fascinating
world out there. Agreed. There's always something
new to discover.